CUSIP 28657F103COMELTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
37 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Knoll Capital Management, LLC | 630.9K | $5.02M | 0 | Held |
| 2 | Vanguard Group Inc | 496.9K | $3.96M | +23.0K | Added |
| 3 | Balyasny Asset Management L.P. | 138.8K | $1.10M | −9.3K | Reduced |
| 4 | Geode Capital Management, LLC | 132.5K | $1.06M |
| +2.8K |
| Added |
| 5 | Marshall Wace, LLP | 117.2K | $932.9K | +30.7K | Added |
| 6 | Susquehanna International Group, LLP | 64.1K | $509.9K | −56.2K | Reduced |
| 7 | 683 Capital Management, LLC | 56.4K | $449.3K | +56.4K | New |
| 8 | Northern Trust Corp | 52.8K | $420.0K | −815 | Reduced |
| 9 | State Street Corp | 46.3K | $368.5K | +8.0K | Added |
| 10 | Blackrock, Inc. | 45.2K | $359.6K | +984 | Added |
See every fund holding Elicio Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders